Clinical trial
Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV…
NCT00052195 · Dartmouth-Hitchcock Medical Center, Other · Completed
Key facts
| NCT number | NCT00052195 |
|---|---|
| Title | Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People |
| Official title | DARDAR Health Project (Disseminated Tuberculosis and HIV Infection) |
| Lead sponsor | Dartmouth-Hitchcock Medical Center, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Tuberculosis, HIV Infections |
| Intervention type | Biological |
| Interventions | SRL-172 |
| Enrollment | 1,975 |
| Start date | Sep 1, 2001 |
| Primary completion | Dec 1, 2008 |
| Completion | May 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 19, 2016 |
| Countries | Tanzania |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: